1,912 results on '"Bussel, James B."'
Search Results
2. Unexpected diagnosis of WHIM syndrome in refractory autoimmune cytopenia
3. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
4. The role of CD8+ T-cell clones in immune thrombocytopenia
5. Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations
6. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
7. Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management.
8. Disorders of platelets
9. List of contributors
10. Immune thrombocytopenia (ITP) in pregnancy
11. Autoimmune Hemolytic Anemia in Adolescent Females
12. Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome.
13. Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study
14. Identification of occult cerebral microbleeds in adults with immune thrombocytopenia
15. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City
16. Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention
17. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia
18. The highs and lows of cyclic thrombocytopenia
19. Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonists
20. Updated international consensus report on the investigation and management of primary immune thrombocytopenia
21. Fetal and Neonatal Alloimmune Thrombocytopenias
22. Does absence of intracranial hemorrhage in the first pregnancy in fetal and neonatal alloimmune thrombocytopenia preclude occurrence in the second?
23. The highs and lows of cyclic thrombocytopenia.
24. A tribute to Paul Imbach
25. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
26. Intramuscular anti‐D treatment for immune thrombocytopenia—Response
27. Management of Primary Immune Thrombocytopenia in Pregnancy
28. List of Contributors
29. Immune Thrombocytopenia: A Complex Autoimmune Disease
30. COVID-19 vaccination and immune thrombocytopenia
31. Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study
32. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone
33. Fetal and neonatal alloimmune thrombocytopenia in 2022
34. Maintenence rituximab following induction in autoimmune cytopenias
35. Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States
36. Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases
37. Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study.
38. Contributors
39. Fetal and Neonatal Alloimmune Thrombocytopenia
40. List of Contributors
41. Acquired Neonatal Thrombocytopenia
42. Immune Thrombocytopenia (ITP)
43. A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemia
44. Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
45. Platelet count control in immune thrombocytopenic purpura patient: Optimum romiplostim dose profile
46. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study
47. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial
48. Romiplostim for Immune Thrombocytopenia in Neuroblastoma Patients Receiving Chemotherapy
49. Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia
50. Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.